Investigation of Sema4A as a biomarker for treatment selection for multiple sclerosis

被引：2
|
作者：
Koda, Toru [1 ]
Okuno, Tatsusada [1 ]
Nakatsujj, Yuji [1 ]
Takata, Kazushiro [1 ]
Honorat, Josephe Archie [1 ]
Namba, Akiko [1 ]
Sakoda, Saburo [2 ]
Kumanogoh, Atsushi [3 ,4 ,5 ]
Mochizuki, Hideki [1 ]
机构：
[1] Osaka Univ, Grad Sch Med, Dept Neurol, Osaka, Japan
[2] Toneyama Natl Hosp, Natl Hosp Org, Osaka, Japan
[3] Osaka Univ, Grad Sch Med, Dept Resp Med, Osaka, Japan
[4] Osaka Univ, Grad Sch Med, Dept Allergy, Osaka, Japan
[5] Osaka Univ, Grad Sch Med, Dept Rheumat Dis, Osaka, Japan
来源：
JOURNAL OF NEUROIMMUNOLOGY | 2014年 / 275卷 / 1-2期
关键词：
D O I：
10.1016/j.jneuroim.2014.08.058
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
140
引用
收藏
页码：20 / 21
页数：2
相关论文
共 50 条
  • [21] Correspondence: Reply to ‘SEMA4A variation and risk of colorectal cancer’
    Heinz Sill
    Eduard Schulz
    Verena Steinke-Lange
    C. Richard Boland
    Nature Communications, 7
  • [22] SEMA4A CAUSES PROCESS COLLAPSE AND APOPTOSIS OF OLIGODENDROCYTE PROGENITORS
    Todorich, B.
    Connor, J. R.
    JOURNAL OF NEUROCHEMISTRY, 2009, 108 : 106 - 107
  • [23] Development of anti-SEMA4D monoclonal antibody for the treatment of multiple sclerosis
    Fisher, T.
    Reilly, C.
    Winter, L.
    Veeraraghavan, J.
    Jonason, A.
    Seils, J.
    Huang, H.
    Bussler, H.
    Klimatcheva, E.
    Decker, J.
    Torno, S.
    Kirk, R.
    Cornelius, C.
    Richards, T.
    Caplan, J.
    Howell, A.
    Kenney, P.
    Scrivens, M.
    Croy, L.
    Pandina, T.
    Doherty, M.
    Seigel, G.
    Evans, E.
    Paris, M.
    Leonard, J.
    Watkins, R.
    Foster, P.
    Zauderer, M.
    Smith, E.
    MULTIPLE SCLEROSIS JOURNAL, 2011, 17 : S206 - S206
  • [24] Development of anti-SEMA4D monoclonal antibody for the treatment of multiple sclerosis
    Jonason, A.
    Klimatcheva, E.
    Fisher, T.
    Reilly, C.
    Winter, L.
    Veeraraghavan, J.
    Seils, J.
    Huang, H.
    Bussler, H.
    Decker, J.
    Torno, S.
    Kirk, R.
    Cornelius, C.
    Richards, T.
    Caplan, J.
    Howell, A.
    Kenney, P.
    Scrivens, M.
    Balch, L.
    Pandina, T.
    Doherty, M.
    Seigel, G.
    Wang, W.
    Evans, E.
    Bowers, W.
    Paris, M.
    Leonard, J.
    Watkins, R.
    Foster, P.
    Zauderer, M.
    Smith, E.
    MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (11) : 240 - 241
  • [25] Development of Anti-SEMA4D Monoclonal Antibody for the Treatment of Multiple Sclerosis
    Smith, Ernest S.
    Fisher, Terrence
    Cornelius, Chad
    Reilly, Christine
    Winter, Laurie
    Veeraraghaven, Janaki
    Jonason, Alan
    Scrivens, Maria
    Parker, Robert
    Seils, Jennifer
    Kirk, Renee
    Richards, Troy
    Caplan, Jeffrey
    Kenney, Patrick
    Croy, Leslie
    Pandina, Tracy
    Torno, Sebold
    Evans, Elizabeth
    Paris, Mark
    Leonard, John
    Watkins, Raymond
    Foster, Paul
    Zauderer, Maurice
    NEUROLOGY, 2011, 76 (09) : A646 - A646
  • [26] Development of anti-SEMA4D monoclonal antibody for the treatment of multiple sclerosis
    Fisher, T.
    Reilly, C.
    Winter, L.
    Veeraraghavan, J.
    Jonason, A.
    Seils, J.
    Huang, H.
    Bussler, H.
    Klimatcheva, E.
    Decker, J.
    Torno, S.
    Kirk, R.
    Cornelius, C.
    Richards, T.
    Caplan, J.
    Howell, A.
    Kenney, P.
    Scrivens, M.
    Croy, L.
    Pandina, T.
    Doherty, M.
    Seigel, G.
    Wang, W.
    Evans, E.
    Bowers, W.
    Paris, M.
    Leonard, J.
    Watkins, R.
    Foster, P.
    Zauderer, M.
    Smith, E.
    MULTIPLE SCLEROSIS JOURNAL, 2012, 18 : 444 - 444
  • [27] Elevation of serum Sema4A in neuromyelitis optica spectrum disorder (NMOsd)
    Okuno, T.
    Koda, T.
    Miyamoto, K.
    Takata, K.
    Kinoshita, M.
    Kusunoki, S.
    Kumanogoh, A.
    Nakatsuji, Y.
    Mochizuki, H.
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 635 - 636
  • [28] Sema4A inhibits the therapeutic effect of IFN-β in EAE
    Koda, Toru
    Okuno, Tatsusada
    Takata, Kazushiro
    Honorat, Josephe Archie
    Kinoshita, Makoto
    Tada, Satoru
    Moriya, Masayuki
    Sakoda, Saburo
    Mochizuki, Hideki
    Kumanogoh, Atsushi
    Nakatsuji, Yuji
    JOURNAL OF NEUROIMMUNOLOGY, 2014, 268 (1-2) : 43 - 49
  • [29] Sema4A Abrogates the Therapeutic Effect of IFN-β on EAE
    Koda, T.
    Okuno, T.
    Honorat, J. A.
    Takata, K.
    Tada, S.
    Kinoshita, M.
    Sakoda, S.
    Kumanogoh, A.
    Mochizuki, H.
    Nakatsuji, Y.
    MULTIPLE SCLEROSIS JOURNAL, 2014, 20 (07) : 912 - 912
  • [30] The role of Sema4A in angiogenesis, immune responses, carcinogenesis, and retinal systems
    Ito, Daisuke
    Kumanogoh, Atsushi
    CELL ADHESION & MIGRATION, 2016, 10 (06) : 692 - 699
12345